A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
Liang, Yayun, Mafuvadze, Benford, Besch-Williford, Cynthia, Hyder, Salman MVolume:
Volume 10
Language:
english
Journal:
Breast Cancer: Targets and Therapy
DOI:
10.2147/BCTT.S156285
Date:
March, 2018
File:
PDF, 7.34 MB
english, 2018